N-(2-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)acrylamide, 95.0%, 1g

5-Hydroxy-2-nitropyridine, 95.0%, 5g

Trial kit Spectra/Por® 1-3 Spectra/Por® 2 - MWCO 12,000–14,000, 45 mm, 1 Piece(s)

4-Bromoquinoline, 98.0%, 10g

2,5-Dimethyl-2 H -pyrazole-3-carboxylic acid hydrazide, 95.0%, 5g

Triethylsilyl Trifluoromethanesulfonate>98.0%(T)5g

4-Hydroxy-benzaldehyde, min. 98%, for synthesis, 50 g, plastic packaging.

Norfloxacin>98.0%(HPLC)(T)5g

2-Iodo-1H-indole, 95.0%, 10g

4-Fluoro-2-methoxyphenol, 97.0%, 25g

(4-(Isobutylsulfonyl)phenyl)boronic acid, 95.0%, 5g

N,N-Diethylformamide>99.0%(GC)500mL

4-Fluoro-7-nitro-indoline, 98%, 100mg